Disclosure Of Cash Flow Statement [Text Block]

Xspray Pharma - Filing #679275

Concept As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
As at
2021-12-31
Disclosure of cash flow statement [text block]
Description of accounting policy for determining components of cash and cash equivalents [text block]
*
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
166 303 SEK
120 166 SEK
271 881 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.